Cargando…
Proceedings of the 2016 China Cancer Immunotherapy Workshop: Beijing, China. 25-26 June 2016
A1 Proceedings of 2016 China Cancer Immunotherapy Workshop, Beijing, China Bin Xue, Jiaqi Xu, Wenru Song, Zhimin Yang, Ke Liu, Zihai Li A2 Set the stage: fundamental immunology in forty minutes Zihai Li A3 What have we learnt from the anti-PD-1/PD-L1 therapy of advanced human cancer? Lieping Chen A4...
Autores principales: | Xue, Bin, Xu, Jiaqi, Song, Wenru, Yang, Zhimin, Liu, Ke, Li, Zihai, Chen, Lieping, Garon, Edward B., Hu-Lieskovan, Siwen, Ding, Wei, Pan, Chong-Xian, Sun, Weijing, Liu, Yong-Jun, Zheng, Lei, Liu, Delong, Sadelain, Michel, Yee, Cassian, Wang, Rongfu, Chen, Meixia, Wang, Yao, Wu, Zhiqiang, Dai, Hanren, Luo, Can, Liu, Yang, Tong, Chuan, Guo, Yelei, Yang, Qingming, Han, Weidong, Butterfield, Lisa H., Chan, Timothy A., Yuan, Ruirong, Lu, Bo, Ning, Max, Enzmann, Harald, Zwierzina, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073990/ http://dx.doi.org/10.1186/s13045-016-0322-x |
Ejemplares similares
-
Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
por: Li, Zihai, et al.
Publicado: (2018) -
PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective
por: Wang, Jun, et al.
Publicado: (2017) -
The role of biomarkers in personalized immunotherapy
por: Sankar, Kamya, et al.
Publicado: (2022) -
Novel strategies for immuno-oncology breakthroughs with cell therapy
por: Liu, Hongtao, et al.
Publicado: (2021) -
Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
por: Pan, Chongxian, et al.
Publicado: (2020)